- Latest week
- 10 Jul 2026
- Close
- 154.050000
- Fair value
- 111.422986
- Next-week expectancy
- Positive 57.33%
NVS Chart Pack
Novartis AG ADR
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, NVS rose 5.90%, moving from 145.47 to 154.05. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 1.00 and has softened across the 12-week window. Market Dynamics is -0.02 on the latest week. Next-week expectancy is positive at 57.33% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 154.05
- 12-Week Change
- 5.90%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 57.33%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 1.00
- Market Dynamics
- -0.02
Weekly Price
Price Action
Smart Money
Market Dynamics
Earnings vs Price
Earnings vs Price
Weekly price against rolling TTM EPS, both indexed to 100 from the first visible week.
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 154.05
- 12-Week Change
- 5.90%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 57.33%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 1.00
- Market Dynamics
- -0.02
Over the latest 12 completed weeks ending 2026-07-10, NVS rose 5.90%, moving from 145.47 to 154.05. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 1.00 and has softened across the 12-week window. Market Dynamics is -0.02 on the latest week. Next-week expectancy is positive at 57.33% based on similar historical setup states.
Industry Peers
United States equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| SCLX Scilex Holding Company | NASDAQ | 10 Jul 2026 | 7.68 | 10.43 | 7.01 | 9.48 | 23.44% |
| GRFS Grifols SA ADR | NASDAQ | 10 Jul 2026 | 7.14 | 7.32 | 7.05 | 7.27 | 1.82% |
| NVO Novo Nordisk A/S | NYSE | 10 Jul 2026 | 49.28 | 50.44 | 48.50 | 49.48 | 0.42% |
| SNY Sanofi ADR | NASDAQ | 10 Jul 2026 | 43.37 | 44.11 | 42.43 | 43.50 | 0.30% |
| PFE Pfizer Inc | NYSE | 10 Jul 2026 | 24.16 | 24.41 | 23.62 | 24.17 | 0.06% |
| OGN Organon & Co | NYSE | 10 Jul 2026 | 13.55 | 13.58 | 13.46 | 13.52 | -0.22% |
| BMY Bristol-Myers Squibb Company | NYSE | 10 Jul 2026 | 57.74 | 58.49 | 56.49 | 57.58 | -0.28% |
| JNJ Johnson & Johnson | NYSE | 10 Jul 2026 | 260.23 | 269.43 | 255.52 | 256.98 | -1.25% |
| LLY Eli Lilly and Company | NYSE | 10 Jul 2026 | 1208.00 | 1249.45 | 1178.32 | 1188.58 | -1.61% |
| MIRA MIRA Pharmaceuticals, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 0.94 | 0.99 | 0.90 | 0.92 | -1.65% |
| GSK GlaxoSmithKline PLC ADR | NYSE | 10 Jul 2026 | 53.80 | 54.29 | 52.30 | 52.78 | -1.90% |
| AMGN Amgen Inc | NASDAQ | 10 Jul 2026 | 371.70 | 375.25 | 359.47 | 363.39 | -2.24% |
| GILD Gilead Sciences Inc | NASDAQ | 10 Jul 2026 | 132.88 | 137.70 | 127.88 | 129.83 | -2.30% |
| MRK Merck & Company Inc | NYSE | 10 Jul 2026 | 129.31 | 130.00 | 122.90 | 123.54 | -4.46% |
| ABBV AbbVie Inc | NYSE | 10 Jul 2026 | 259.92 | 260.92 | 245.05 | 248.08 | -4.56% |
| MDCX Medicus Pharma Ltd. Common Stock | NASDAQ | 10 Jul 2026 | 0.43 | 0.47 | 0.40 | 0.41 | -4.77% |